<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJGas</journal-id><journal-title-group><journal-title>Open Journal of Gastroenterology</journal-title></journal-title-group><issn pub-type="epub">2163-9450</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojgas.2018.89034</article-id><article-id pub-id-type="publisher-id">OJGas-87517</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Role of Nerve Growth Factor (NGF) and Its Receptor Tyrosine Kinase A (TrK A) in Egyptian Cirrhotic Patients with Pruritus
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Amr</surname><given-names>Zaghloul</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hanan</surname><given-names>Assaf</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Reham</surname><given-names>Ezz</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mohamed</surname><given-names>Malak</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mahmoud</surname><given-names>Rezk</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ashraf</surname><given-names>Askar</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Essam</surname><given-names>El-dinNada</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Sohag University Hospital, Sohag, Egypt</addr-line></aff><pub-date pub-type="epub"><day>19</day><month>09</month><year>2018</year></pub-date><volume>08</volume><issue>09</issue><fpage>317</fpage><lpage>326</lpage><history><date date-type="received"><day>23,</day>	<month>July</month>	<year>2018</year></date><date date-type="rev-recd"><day>23,</day>	<month>September</month>	<year>2018</year>	</date><date date-type="accepted"><day>26,</day>	<month>September</month>	<year>2018</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  <b>Background:</b> Pruritus is a distressing symptom of cholestatic, inflammatory, and malignant liver diseases. It is a common symptom in many biliary and cholestatic disorders such as primary biliary cirrhosis (PBC). Several mechanisms are generally accepted as possible explanations to the underlying basis of itch. However, the exact pathophysiology of pruritus in liver diseases remains unclear. The cutaneous and central neurobiology of pruritus is complex and underlies a regulation of variable mechanisms. At present, not all mechanisms including neuromediators and receptors are known. 
  <b>Objective:</b> Our objective is to evaluate whether the expression pattern of NGF and its receptor TrK A has a role in pruritus in a group of Egyptian cirrhotic patients. 
  <b>Patients and Methods:</b> Forty Patients with liver cirrhosis were enrolled in the study depending on clinical evidence of stigmata of chronic liver disease (e.g. jaundice, ascites, palmar erythema, spider naevi, etc.) and ultrasonographic features of liver cirrhosis (e.g. coarse echo texture, shrunken liver, etc.). Patients were divided into two groups. Group (1): included 20 patients cirrhotic patients without pruritus. Group (2): included 20 patients cirrhotic patients with pruritus. A group of age and sex matched healthy twenty volunteers as a control. 
  <b>Results:</b> After evaluation of histopathological using hematoxylin and eosin stained sections (H&amp;E) was done. There was positive correlation between NGF protein expression and severity of pruritus in cirrhotic patients with pruritus (r = 0.876, p value ≤ 0.001). Also there was positive correlation between TrK A protein expression and severity of pruritus in cirrhotic patients with pruritus (r = 0.44, p value ≤ 0.05). 
  <b>Conclusions:</b> We report, for the first time, role of these proteins (NGF/TrK A) in the mechanism of pruritus in cirrhotic patients and may provide a potential target for new treatment of pruritus in cirrhotic.
 
</p></abstract><kwd-group><kwd>Liver Cirrhosis</kwd><kwd> Itching</kwd><kwd> Nerve Growth Factor (NGF) and Its Receptor  Tyrosine Kinase A (TrK A)</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Chronic pruritus or itch (defined as lasting for at least 6 weeks) [<xref ref-type="bibr" rid="scirp.87517-ref1">1</xref>] is a common symptom associated with many dermatological diseases [<xref ref-type="bibr" rid="scirp.87517-ref2">2</xref>] , such as eczema orcontact dermatitis, and with psychiatric and neurological disorders [<xref ref-type="bibr" rid="scirp.87517-ref3">3</xref>] .</p><p>Pruritus is a distressing symptoms of cholestatic, inflammatory, and malignant liver diseases [<xref ref-type="bibr" rid="scirp.87517-ref4">4</xref>] . It is a common symptom in many biliary and cholestatic disorders such as primary biliary cirrhosis (PBC) [<xref ref-type="bibr" rid="scirp.87517-ref5">5</xref>] .</p><p>Several mechanisms are generally accepted as possible explanations to the underlying basis of itch [<xref ref-type="bibr" rid="scirp.87517-ref6">6</xref>] . However, the exact pathophysiology of pruritus in liver diseases remains unclear [<xref ref-type="bibr" rid="scirp.87517-ref7">7</xref>] .</p><p>The cutaneous and central neurobiology of pruritus is complex and underlies a regulation of variable mechanisms [<xref ref-type="bibr" rid="scirp.87517-ref8">8</xref>] . At present, not all mechanisms including neuromediators and receptors are known [<xref ref-type="bibr" rid="scirp.87517-ref9">9</xref>] .</p><p>The common ectodermal origin of nervous system and the skin suggests that growth factors regulating the development and function of neurons are also involved in the control of skin homeostasis and remodeling [<xref ref-type="bibr" rid="scirp.87517-ref10">10</xref>] .</p><p>Neurotrophins (NTs) belong to a group of functionally and structurally related proteins, the neurotrophic factors’ family that were first identified as promoters for neuronal survival [<xref ref-type="bibr" rid="scirp.87517-ref11">11</xref>] .</p><p>Nerve growth factor (NGF) was the first NT to be discovered during a search for survival factors. Two Brain-derived neurotrophic factor (BDNF) was the second NT to be characterized. It has been identified as a survival factor for several neuronal populations not responsive to NGF. There are four NTs are expressed in mammals: NGF, BDNF, NT-3 NT-4. NT plays a critical role in neurobiological aspect of mental development [<xref ref-type="bibr" rid="scirp.87517-ref10">10</xref>] .</p><p>Nerve growth factor (NGF) and its receptor tyrosine kinase A (TrK A) were shown to be expressed in healthy human skin where they are involved in sensitization of peripheral neuroreceptors such as the histamine and capsaicin (TRPV1) receptor [<xref ref-type="bibr" rid="scirp.87517-ref12">12</xref>] .</p></sec><sec id="s2"><title>2. Aim of the Study</title><p>The present study aims to explore the expression pattern of NGF and its receptor TrK A in cirrhotic patients with pruritis in comparison to cirrhotic patients without pruritus and to evaluate correlations between tissue levels of measured parameters and severity of the disease.</p></sec><sec id="s3"><title>3. Patients and Methods</title><p>This case-control hospital based study was carried out at the Department of Dermatology Venereology and Andrology jointly with Department of Gastroenterology and Tropical Medicine at Sohag University Hospitals Egypt.</p></sec><sec id="s4"><title>4. Inclusion Criteria</title><p>This study included 40 patients diagnosed with liver cirrhosis depending on clinical evidence of stigmata of chronic liver disease (e.g. jaundice, ascites, palmar erythema, spider naevi, etc.) and ultrasonographic features of liver cirrhosis (e.g. coarse echo texture, shrunken liver, etc.) during the period between January 2018 till June 2018.</p><p>Patients were divided into two groups.</p><p>Group (1): included 20 patients cirrhotic patients without pruritus.</p><p>Group (2): included 20 patients cirrhotic patients with pruritus.</p><p>A group of age and sex matched healthy twenty volunteers as a control.</p><sec id="s4_1"><title>4.1. Exclusion Criteria</title><p>1) Patients with history of associated endocinal disorders e.g., diabetes mellitus, thyroid disease or chronic renal illness.</p><p>2) Patients presented with itchy or non itchy dermatosis.</p></sec><sec id="s4_2"><title>4.2. Ethical Consideration</title><p>The study was approved by the Ethics Committee on Research Involving Human Subjects at University of Sohag. All individuals invited were informed in detail about the investigation and voluntarily signed the Informed Consent Form with respect to patient’s confidentiality.</p></sec><sec id="s4_3"><title>4.3. Methods of the Study</title><p>Each patient included in the study was subjected to:</p><p>• Complete history taking and physical examination</p><p>Laboratory investigations: total &amp; differential bilirubin, Aspartate aminotransferase (AST), Alanine aminotransferase (ALT), serum alkaline phosphatase, serum albumin, prothrombin time and concentration, total &amp; differential bilirubin, hepatitis markers for HBV and HCV, serum creatinine, Haemoglobin level (Hb).</p><p>• Assessment of the severity of liver disease</p><p>The functional severity of liver disease was assessed using the Child-Pugh grading system [<xref ref-type="bibr" rid="scirp.87517-ref13">13</xref>] .</p><p>Child (A) 5 - 6.</p><p>Child (B) 7 - 9.</p><p>Child (C) 10 - 15.</p><p>• Abdominal ultrasonography</p><p>To evaluate liver (size, echogenicity and any focal lesion), portal vein, spleen, portosystemic collaterals, and detect ascites.</p><p>Dermatological examination: complete dermatological examination was performed including skin, mucous membranes, hair and nails.</p><p>The severity of itching was assessed with the 5-D itch score [<xref ref-type="bibr" rid="scirp.87517-ref14">14</xref>] . It is a brief but multidimensional questionnaire. The five dimensions are degree, duration, direction, disability and distribution.</p><p>Skin biopsies and immunohistochemical evaluation: punch skin biopsies (4 mm) each were obtained from each included patient and the control fixation was done using 10% neutral phosphate-buffered formalin for 24 hours. The formalin fixed-paraffin embedded tissues were processed for routine histology (Hematoxylin and eosin stains) and special (Giemsa stain) as well as immunohistochemical stains at the Department of Pathology.</p></sec></sec><sec id="s5"><title>5. Statistical Analysis</title><p>Data was analyzed using SPSS computer program version 22.0.</p><p>Quantitative data was expressed as means &#177; standard deviation, median and range. Qualitative data was expressed as number and percentage. The data were tested for normality using Shapiro-Wilk test. The non parametric Man-Whitney test, Kruskal-Wallis test and Spearman’s correlation were used for data which wasn’t normally distributed.</p><p>One-Way ANOVA test and Pearson’s correlation were used for normally distributed data. Chi-Square test was used for comparison between qualitative variables. A 5% level was chosen as a level of significance in all statistical tests used in the study.</p></sec><sec id="s6"><title>6. Results</title><p>The study included 40 patients with mean age (52 &#177; 9.1) were divided into two groups; cirrhotic patients with pruritus (N = 20), cirrhotic patients without pruritus (N = 20) as well as 20 age and sex matched healthy volunteers as a control group.</p><p>The main aetiology of liver cirrhosis was HCV infection in 50% of cases.</p><p>There were no significant differences between the two groups as regard age and gender as shown in <xref ref-type="table" rid="table1">Table 1</xref>.</p><p><xref ref-type="table" rid="table2">Table 2</xref> showed no significant differences between the two groups as regard the clinical and the laboratory parameters.</p><p>The itching was severe among patients with HCV infection as shown in <xref ref-type="table" rid="table3">Table 3</xref>.</p><p>There was positive correlation between NGF protein expression and severity of pruritus in cirrhotic patients with pruritus (r = 0.876, p value ≤ 0.001) as shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</p><p>There was positive correlation between TrK A protein expression and severity of pruritus in cirrhotic patients with pruritus (r = 0.44, p value ≤ 0.05) as shown in <xref ref-type="fig" rid="fig2">Figure 2</xref>.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Demographic characteristics are summarized in <xref ref-type="table" rid="table1">Table 1</xref> and there were no significant differences between the two groups as regards any of these parameters</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Parameter</th><th align="center" valign="middle" >Group 1 (without pruritus) (N = 20)</th><th align="center" valign="middle" >Group 2 (with pruritus) (N = 20)</th><th align="center" valign="middle" >p-value</th></tr></thead><tr><td align="center" valign="middle" >Age Mean &#177; S.D. Median (Range)</td><td align="center" valign="middle" >55.7 &#177; 5.3 55 (47 - 67)</td><td align="center" valign="middle" >52.7 &#177; 9.1 55 (35 - 67)</td><td align="center" valign="middle" >0.234*</td></tr><tr><td align="center" valign="middle" >Gender Males Females</td><td align="center" valign="middle" >11 (55%) 9 (45%)</td><td align="center" valign="middle" >9 (45%) 11 (55%)</td><td align="center" valign="middle" >0.766**</td></tr></tbody></table></table-wrap><p>*p-value was calculated by Kruskal Wallis test; **p-value was calculated by Chi-Square test.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Clinical and laboratory characteristics of studied population</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Characteristics</th><th align="center" valign="middle" ></th></tr></thead><tr><td align="center" valign="middle" >Ascites No Yes</td><td align="center" valign="middle" >19 (47.5%) 21 (52.5%)</td></tr><tr><td align="center" valign="middle" >Lower limb edema No Yes</td><td align="center" valign="middle" >29 (72.5%) 11 (27.5%)</td></tr><tr><td align="center" valign="middle" >Jaundice No Yes</td><td align="center" valign="middle" >25 (62.5%) 15 (37.5%)</td></tr><tr><td align="center" valign="middle" >Aetiology of liver cirrhosis HBV HCV Mixed Unknown</td><td align="center" valign="middle" >10 (25%) 21 (52.5%) 6 (15%) 3 (7.5%)</td></tr><tr><td align="center" valign="middle" >ALT (IU/L) Mean &#177; S.D. Median (Range)</td><td align="center" valign="middle" >32.6 &#177; 5.8 30.5 (24 - 45)</td></tr><tr><td align="center" valign="middle" >Bilirubin (mg/dl) Mean &#177; S.D. Median (Range)</td><td align="center" valign="middle" >2.4 &#177; 1.2 2.4 (1 - 6)</td></tr><tr><td align="center" valign="middle" >Albumin (mg/dl) Mean &#177; S.D. Median (Range)</td><td align="center" valign="middle" >3.3 &#177; 0.7 3.3 (2 - 4.5)</td></tr><tr><td align="center" valign="middle" >Prothrombin Mean &#177; S.D. Median (Range)</td><td align="center" valign="middle" >4.7 &#177; 1.2 4.6 (3 - 7)</td></tr></tbody></table></table-wrap></sec><sec id="s7"><title>7. Histopathological Findings</title><p>Evaluation of histopathological using hematoxylin and eosin stained sections (H&amp;E) was done and compared among the studied three groups as shown in <xref ref-type="table" rid="table4">Table 4</xref>. In the skin biopsy specimens of the cirrhotic patients with pruritus we found several histological changes including: epidermal hyperplasia (acanthosis),</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Comparison between group 1 and group 2 regarding clinical and laboratory data</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Parameter</th><th align="center" valign="middle" >Group 1 (without pruritus) (N = 20)</th><th align="center" valign="middle" >Group 2 (with pruritus) (N = 20)</th><th align="center" valign="middle" >p-value</th></tr></thead><tr><td align="center" valign="middle" >Ascites No Yes</td><td align="center" valign="middle" >7 (35%) 13 (65%)</td><td align="center" valign="middle" >12 (60%) 8 (40%)</td><td align="center" valign="middle" >0.113*</td></tr><tr><td align="center" valign="middle" >Lower limb edema No Yes</td><td align="center" valign="middle" >14 (70%) 6 (30%)</td><td align="center" valign="middle" >15 (75%) 5 (25%)</td><td align="center" valign="middle" >0.723*</td></tr><tr><td align="center" valign="middle" >Jaundice No Yes</td><td align="center" valign="middle" >12 (60%) 8 (40%)</td><td align="center" valign="middle" >13 (65%) 7 (35%)</td><td align="center" valign="middle" >0.744*</td></tr><tr><td align="center" valign="middle" >ALT (IU/L) Mean &#177; S.D. Median (Range)</td><td align="center" valign="middle" >31.9 &#177; 5.04 30 (25 - 45)</td><td align="center" valign="middle" >33.4 &#177; 6.6 31 (24 - 45)</td><td align="center" valign="middle" >0.673 **</td></tr><tr><td align="center" valign="middle" >Bilirubin (mg/dl) Mean &#177; S.D. Median (Range)</td><td align="center" valign="middle" >2.6 &#177; 1.3 2.5 (1 - 6)</td><td align="center" valign="middle" >2.2 &#177; 1.08 1.9 (1 - 4.1)</td><td align="center" valign="middle" >0.481 **</td></tr><tr><td align="center" valign="middle" >Albumin (mg/dl) Mean &#177; S.D. Median (Range)</td><td align="center" valign="middle" >3.2 &#177; 0.7 3.1 (2 - 4.5)</td><td align="center" valign="middle" >3.4 &#177; 0.7 3.6 (2.1 - 4.5)</td><td align="center" valign="middle" >0.231 **</td></tr><tr><td align="center" valign="middle" >Prothrombin Mean &#177; S.D. Median (Range)</td><td align="center" valign="middle" >4.8 &#177; 1.3 4.8 (3 - 7)</td><td align="center" valign="middle" >4.5 &#177; 1.3 4.1 (3 - 6.8)</td><td align="center" valign="middle" >0.341 **</td></tr><tr><td align="center" valign="middle" >Stage of liver cirrhosis Stage A Stage B Stage C</td><td align="center" valign="middle" >6 (30%) 9 (45%) 5 (25%)</td><td align="center" valign="middle" >10 (50%) 6 (30%) 4 (20%)</td><td align="center" valign="middle" >0.425**</td></tr></tbody></table></table-wrap><p>*p-value was calculated by Chi-Square test; **p-value was calculated by Mann-Whitney U Test.</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Relation between severity score of pruritus and cause of cirrhosis</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Severity score</th><th align="center" valign="middle" >HBV (N = 4)</th><th align="center" valign="middle" >HCV (N = 10)</th><th align="center" valign="middle" >Mixed (N = 3)</th><th align="center" valign="middle" >Unknown (N = 3)</th><th align="center" valign="middle" >p-value</th></tr></thead><tr><td align="center" valign="middle" >Mean &#177; S.D. Median (Range)</td><td align="center" valign="middle" >10 &#177; 1.2 10 (9 - 11)</td><td align="center" valign="middle" >19.3 &#177; 3.1 19.5 (14 - 24)</td><td align="center" valign="middle" >12.7 &#177; 2.5 13 (10 - 15)</td><td align="center" valign="middle" >11.7 &#177; 2.5 2 (9 - 14)</td><td align="center" valign="middle" >0.003*</td></tr></tbody></table></table-wrap><p>*p-value was calculated by Kruskal Wallis test. *Statistically significant.</p><p>vascular ectasia (dilated dermal blood vessels), hypertrophied dermal nerve endings, leucocytoclasia (swelling of the endothelial cell lining of the blood vessels without fibrinoid necrosis, or extravasation of red blood cells) and lymphocytic vasculopathy. Evaluation of mast cell count in Gimesa stained skin sections revealed an increased numbers of these cells in the group of cirrhotic patients with pruritus (N = 5 - 10). The cells noted in perivascular, perineural and interstitial distribution (between collagen bundles) (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p></sec><sec id="s8"><title>8. Discussion</title><p>Pruritus is a common symptom in hepatobiliary disorders, particularly in those related to cholestasis [<xref ref-type="bibr" rid="scirp.87517-ref15">15</xref>] . Its prevalence is variable among liver diseases, ranging from 5% in chronic hepatitis C virus infection to 70% in primary biliary cirrhosis [<xref ref-type="bibr" rid="scirp.87517-ref16">16</xref>] .</p><p>Despite the major advances in the last 15 years in the study of pruritus it remains unclear how peripheral and central mechanisms take place, increased production and release of cytokines, neuropeptides and neurotrophins possibly</p><p>lead to exacerbation of pruritus [<xref ref-type="bibr" rid="scirp.87517-ref17">17</xref>] .</p><p>To the best of our knowledge, there were no previous studies that investigated the expression pattern of NGF and its receptor TrK A in cirrhotic patients with pruritus.</p><p>We carried out this investigation using immunohistochemical technique to fill this existing gap in literature and to test our hypothesis.</p><p>We found also increased numbers of mast cells which have perivascular, perineural and interstitial distribution and bile acids are known to be potent activators of mast cells causing histamine excretion that might also constitute the reason for itch [<xref ref-type="bibr" rid="scirp.87517-ref18">18</xref>] .</p><p>In the current study, the expression pattern of NGF protein in the skin of cirrhotic patients with pruritus in comparison to non-pruritus and normal healthy skins.was higher in both the epidermis and dermal adnexal structures in cirrhotic patients with pruritus and this agree with Dou et al. [<xref ref-type="bibr" rid="scirp.87517-ref9">9</xref>] who reported that there were higher levels of NGF in the keratinocytes of the epidermal basal and spinal layers, and more in dermal infiltrating inflammatory cells in the early atopic dermatitis lesion, compared to the controls.</p><p>The study also demonstrate that there is a relation between severity of pruritus and HCV as a cause of cirrhosis, Desphande et al. [<xref ref-type="bibr" rid="scirp.87517-ref19">19</xref>] found that the mechanisms of HCV-associated pruritus are attributed to HCV-induced cholestasis and the induction of interferon-stimulated genes as a result of viral overload.</p><p>The elevated production of cytokines (e.g., IL-8) and chemokines during the course of cholestatic HCV is expected to be the main mediators for the induction of HCV-associated pruritus [<xref ref-type="bibr" rid="scirp.87517-ref20">20</xref>] .</p><p>In conclusion, Our novel findings suggest a pathophysiological role of these proteins (NGF/TrK A) in the mechanism of pruritus in cirrhotic patients and may provide a potential target for new treatment of pruritus in cirrhotic patients.</p></sec><sec id="s9"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s10"><title>Cite this paper</title><p>Zaghloul, A., Assaf, H., Ezz, R., Malak, M., Rezk, M., Askar, A. and El-dinNada, E. (2018) Role of Nerve Growth Factor (NGF) and Its Receptor Tyrosine Kinase A (TrK A) in Egyptian Cirrhotic Patients with Pruritus. Open Journal of Gastroenterology, 8, 317-326. https://doi.org/10.4236/ojgas.2018.89034</p></sec></body><back><ref-list><title>References</title><ref id="scirp.87517-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">St&amp;#228;nder, S., Weisshaar, E., Mettang, T., Szepietowski, J.C., Carstens, E., Ikoma, A., et al. (2007) Clinical Classification of Itch: A Position Paper of the International Forum for the Study of Itch. Acta Dermato-Venereologica, 87, 291-294. https://doi.org/10.2340/00015555-0305</mixed-citation></ref><ref id="scirp.87517-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Sommer, F., Hensen, P., b&amp;#246;ckenholt, B., Metze, D., Luger, T.A. and St&amp;#228;nder, S. (2007) Underlying Diseases and, Co-Factors in Patients with Severe Chronic Pruritus: A 3-Year Retrospective Study. Acta Dermato-Venereologica, 87, 510-516. https://doi.org/10.2340/00015555-0320</mixed-citation></ref><ref id="scirp.87517-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Weisshaar, E., Apfelbacher, C., Jager, G., Zimmermann, E., Bruckner, T., Diepgen, T.L. and Gollnick, H. (2006) Pruritus as a Leadingsymptom: Clinical Characteristics and Quality of Life Ingerman and Ugandan Patients. British Journal of Dermatology, 155, 957-964. https://doi.org/10.1111/j.1365-2133.2006.07430.x</mixed-citation></ref><ref id="scirp.87517-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Bergasa, N.V. (2011) The Itch of Liver Disease. Seminars in Cutaneous Medicine and Surgery, 30, 8-93. https://doi.org/10.1016/j.sder.2011.04.009</mixed-citation></ref><ref id="scirp.87517-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Zein, C.O. and Lindor, K.D. (2010) Latest and Emerging Therapies for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis. Current Gastroenterology Reports, 12, 13-22. https://doi.org/10.1007/s11894-009-0079-2</mixed-citation></ref><ref id="scirp.87517-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Patel, K.N. and Dong, X. (2011) Itch: Cells, Molecules, and Circuits. ACS Chemical Neuroscience, 2, 17-25.</mixed-citation></ref><ref id="scirp.87517-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Oude Elferink, R.P., Kremer, A.E., Martens, J.J. and Beuers, U.H. (2011) The Molecular Mechanism of Cholestatic Pruritus. Digestive Diseases, 29, 66-71. https://doi.org/10.1159/000324131</mixed-citation></ref><ref id="scirp.87517-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Nockher, W.A. and Renz, H. (2006) Neurotrophins in Allergic Diseases: From Neuronal Growth Factor to Intercellular Signaling Molecules. Journal of Allergy and Clinical Immunology, 117, 583-589. https://doi.org/10.1016/j.jaci.2005.11.049</mixed-citation></ref><ref id="scirp.87517-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Dou, Y., Hagstromer, L. and Emtestam, L. (2006) Increased Nerve Growth Factor and Its Receptors in Atopic Dermatitis: An Immunohistochemical Study. Archives of Dermatological Research, 298, 31-37. https://doi.org/10.1007/s00403-006-0657-1</mixed-citation></ref><ref id="scirp.87517-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Botchkarev, V., Peters, E. and Paus, R. (2004) Epithelial Growth Control by Neurotrophins: Leads and Lessons from the Hair Follicle. Progress in Brain Research, 146, 493-513. https://doi.org/10.1016/S0079-6123(03)46031-7</mixed-citation></ref><ref id="scirp.87517-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Pincelli, C. and Yaar, M. (1997) Nerve Growth Factor: Its Significance in Cutaneous Biology. Journal of Investigative Dermatology Symposium Proceedings, 2, 61-68.https://doi.org/10.1038/jidsymp.1997.8</mixed-citation></ref><ref id="scirp.87517-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Papoiu, A.D.P., Wang, H., Nattkemper, L., et al. (2011) A Study of Serum Concentrations and Dermal Levels of NGF in Atopic Dermatitis and Healthy Subjects. Neuropeptides, 45, 417-422. https://doi.org/10.1016/j.npep.2011.07.008</mixed-citation></ref><ref id="scirp.87517-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Pugh, R., Murray Lyon, I., Dawson, J., Pietroni, M. and Williams, R. (1973) Transection of the Oesophagus for Bleeding Oesophageal Varices. British Journal of Surgery, 60, 646-649. https://doi.org/10.1002/bjs.1800600817</mixed-citation></ref><ref id="scirp.87517-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Elman, S., Hynan, L., Gabriel, V. and Mayo, M. (2010) The 5-D Itch Scale: A New Measure of Pruritus. British Journal of Dermatology, 162, 587-593. https://doi.org/10.1111/j.1365-2133.2009.09586.x</mixed-citation></ref><ref id="scirp.87517-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Lindor, K., Gershwin, M., Poupon, R., Kaplan, M. and Bergasa, N. (2009) Primary Biliary Cirrhosis. Hepatology, 50, 291-308. https://doi.org/10.1002/hep.22906</mixed-citation></ref><ref id="scirp.87517-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Jones, D. (2012) Pathogenesis of Cholestatic Itch: Old Questions, New Answers and Future Opportunities. Hepatology, 56, 1194-1196. https://doi.org/10.1002/hep.25847</mixed-citation></ref><ref id="scirp.87517-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Raap, U. and Kapp, A. (2005) Neuroimmunological Findings in Allergic Skin Diseases. Current Opinion in Allergy and Clinical Immunology, 5, 419-424. https://doi.org/10.1097/01.all.0000183111.78558.4d</mixed-citation></ref><ref id="scirp.87517-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Michalak, A., Hanc, M., Fatyga, A. and Skublewska, A. (2011) Pruritus in Liver Disease—Pathogenesis and Treatment. Journal of Pre-Clinical and Clinical Research, 5, 47-49.</mixed-citation></ref><ref id="scirp.87517-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Desphande, V., Burd, E., Aardema, K. and Moonka, D. (2001) High Levels of Hepatitis C Virus RNA in Native Livers Correlate with the Development of Cholestatic Hepatitis in Liver Allografts and a Poor Outcome. Liver Transplantation, 7, 118-124. https://doi.org/10.1053/jlts.2001.21278</mixed-citation></ref><ref id="scirp.87517-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Zekri, A., Bahnassy, A., Mohamed, W., Alam El-Din, H. and Shousha, H. (2013) Dynamic Interplay between CXCL Levels in Chronic Hepatitis C Patients Treated by Interferon. Virology Journal, 10, 218. https://doi.org/10.1186/1743-422X-10-218</mixed-citation></ref></ref-list></back></article>